NASDAQ:LYEL | EBITDA | Lyell Immunopharma, Inc.

Complete source-backed ebitda history.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical EBITDA

DateEBITDA
2026-03-31-$41.93M
2025-12-31-$125.25M
2025-03-31-$53.93M
2024-12-31-$196.12M
2024-03-31-$50.55M
2023-12-31-$54.45M
2023-03-31-$57.53M
2022-12-31-$9.74M
2022-03-31-$64.39M
2021-12-31-$42.97M
2021-03-31-$53.41M
2020-12-31-$38.07M

Annual EBITDA

DateEBITDA
2025-12-31-$257.87M
2024-12-31-$339.12M
2023-12-31-$226.76M
2022-12-31-$169.04M
2021-12-31-$201.15M
2020-12-31-$207.64M
2019-12-31-$100.83M